Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yasuo Miyoshi

Showing results (171-180 of 178) with videos related to

Pageof 18
Sort By:
You have reached the last page of results.This site can display upto 178 results.
Cancer Medicine|November 8, 2022
Lack of impact of the ALDH2 rs671 variant on breast cancer development in Japanese BRCA1/2-mutation carriersTomoharu Mori, Yusuke Okamoto, Anfeng Mu, et al.
Breast Cancer (Tokyo, Japan)|March 17, 2023
Copy number alteration is an independent prognostic biomarker in triple-negative breast cancer patientsMasayuki Nagahashi, YiWei Ling, Chie Toshikawa, et al.
JCO Precision Oncology|June 13, 2020
Actionable gene alterations in an Asian population with triple-negative breast cancerMasayuki Nagahashi, YiWei Ling, Tetsu Hayashida, et al.
Cancer Research|March 18, 2004
NY-ESO-1 expression and immunogenicity in malignant and benign breast tumorsYurika Sugita, Hisashi Wada, Shoichiro Fujita, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 17, 2025
KEYLYNK-009: Pembrolizumab Plus Olaparib in Locally Recurrent Inoperable or Metastatic Triple-Negative Breast Cancer and Clinical Benefit From First-Line Pembrolizumab Plus ChemotherapyHope S Rugo, David W Cescon, Mark E Robson, et al.
International Journal of Clinical Oncology|September 29, 2015
Risk factors for joint symptoms in postmenopausal Japanese breast cancer patients treated with anastrozole: a prospective multicenter cohort study of patient-reported outcomesChiyomi Egawa, Kouichi Hirokaga, Shintaro Takao, et al.
Breast Cancer (Tokyo, Japan)|October 13, 2016
Body mass index and menopausal disorders during menopause affect vasomotor symptoms of postmenopausal Japanese breast cancer patients treated with anastrozole: a prospective multicenter cohort study of patient-reported outcomesKaori Tane, Chiyomi Egawa, Shintaro Takao, et al.
Lancet (London, England)|April 22, 2023
Trastuzumab deruxtecan versus treatment of physician's choice in patients with HER2-positive metastatic breast cancer (DESTINY-Breast02): a randomised, open-label, multicentre, phase 3 trialFabrice André, Yeon Hee Park, Sung-Bae Kim, et al.
Pageof 18

Showing results (171-180 of 178) with videos related to

Sort By:
Pageof 18
You have reached the last page of results.This site can display upto 178 results.
Cancer Medicine|November 8, 2022
Lack of impact of the ALDH2 rs671 variant on breast cancer development in Japanese BRCA1/2-mutation carriersTomoharu Mori, Yusuke Okamoto, Anfeng Mu, et al.
Breast Cancer (Tokyo, Japan)|March 17, 2023
Copy number alteration is an independent prognostic biomarker in triple-negative breast cancer patientsMasayuki Nagahashi, YiWei Ling, Chie Toshikawa, et al.
JCO Precision Oncology|June 13, 2020
Actionable gene alterations in an Asian population with triple-negative breast cancerMasayuki Nagahashi, YiWei Ling, Tetsu Hayashida, et al.
Cancer Research|March 18, 2004
NY-ESO-1 expression and immunogenicity in malignant and benign breast tumorsYurika Sugita, Hisashi Wada, Shoichiro Fujita, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 17, 2025
KEYLYNK-009: Pembrolizumab Plus Olaparib in Locally Recurrent Inoperable or Metastatic Triple-Negative Breast Cancer and Clinical Benefit From First-Line Pembrolizumab Plus ChemotherapyHope S Rugo, David W Cescon, Mark E Robson, et al.
International Journal of Clinical Oncology|September 29, 2015
Risk factors for joint symptoms in postmenopausal Japanese breast cancer patients treated with anastrozole: a prospective multicenter cohort study of patient-reported outcomesChiyomi Egawa, Kouichi Hirokaga, Shintaro Takao, et al.
Breast Cancer (Tokyo, Japan)|October 13, 2016
Body mass index and menopausal disorders during menopause affect vasomotor symptoms of postmenopausal Japanese breast cancer patients treated with anastrozole: a prospective multicenter cohort study of patient-reported outcomesKaori Tane, Chiyomi Egawa, Shintaro Takao, et al.
Lancet (London, England)|April 22, 2023
Trastuzumab deruxtecan versus treatment of physician's choice in patients with HER2-positive metastatic breast cancer (DESTINY-Breast02): a randomised, open-label, multicentre, phase 3 trialFabrice André, Yeon Hee Park, Sung-Bae Kim, et al.
Pageof 18